However, while our findings suggest that these particular polymorphisms may not be significant risk factors for CRC in this cohort, future research should explore the broader implications of VDR polymorphisms, particularly in relation to cancer progression, recurrence, survival, and drug resistance. This evidence concerns the gene VDR and cancer.